Warwick Smith has stepped down as head of the British Generic Manufacturers Association and British Biosimilars Association, to be replaced by Mark Samuels as CEO.
Warwick Smith has stepped down from his position as director general of the British Generic Manufacturers Association and British Biosimilars Association and has been replaced by new CEO Mark Samuels, the BGMA has announced today. Smith is retiring from the role after 25 years at the helm of the off-patent industry association.
Former Roche executive Samuels is co-founder of the government-funded, non-profit Medicines Discovery Catapult organization, and was also founding managing director...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
